Jump to Navigation
Trends and Sentiments
Comments and Analysis
JPMorgan to face U.S. class action in $10 billion MBS case
Ackman’s Pershing Square raises $3-billion in Amsterdam...
Microsoft unveils Windows 10
Royal Enfield sales up 65 per cent in September
Are pampered rich wrecking cantonal finances?
Japan stock orders of $617-billion scrapped in ‘fat...
Indonesia's XL Axiata Sells Telecom Towers
Adidas seeks to placate investors with share buyback
UBM Agrees to Buy Advanstar
A Report Says Angie's List Might Sell Itself And Now...
Good News for Vical Cancer Drug Candidate
Vical, Inc. Q4 2009 Earnings Call Transcript
Biotech Deal Activity Takes a Breather
7 Companies in the Race to Find Cures for Cancer
Vical Incorporated Q1 2010 Earnings Call Transcript
Vical Incorporated. Q2 2010 Earnings Call Transcript
Sanofi Failure Opens Door for Aastrom Bio
Bottom Fishing: Any Value in September's Losers?
15 Biotech Stocks With the Lowest Put/Call Ratios
Vical Analyst and Investor Day Transcript
Seven Stocks With CEO Buying in the Past Week
Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript
18 Stocks on the 52 Week Low List Ready to Pop?
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Vical Is Deeply Undervalued: Technology and Pipeline Offer Upside Reward
Major FDA Approval Could Pave the Way for These 5 Biotechs
Vical: A Biotech Flying Under the Radar
Chinese CEOs: Cook Your Books at Your Own Peril
7 Dirt Cheap Biotech Stocks With Huge Upside
Breakouts: 6 Stocks Showing New Strength
Vical's CEO Discusses Q1 2011 Results - Earnings Call Transcript
4 Biotech Stocks with Extremely Bearish Options Sentiment
Personalized Medicine for the Masses
Careful Analysis Reveals Good Probability of Gains for Vical
How to Change the World—and Make Some Money Too
Eurozone manufacturing in doldrums, Markit index...
EUR/GBP: 1.2855 USD/EUR: 1.2599 JPY/USD: 109.841
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions